Liping Dai
Harbin Engineering University(CN)Wuhan University(CN)Zhengzhou University(CN)Fourth People's Hospital of Sichuan Province(CN)Institute of Urban Environment(CN)Fujian Polytechnic of Information Technology(CN)City University College of Science and Technology(MY)Renmin Hospital of Wuhan University(CN)Henan Cancer Hospital(CN)First Affiliated Hospital of Henan University(CN)Zhengzhou Business University(CN)Comprehensive Clinical Research(US)Tohoku Medical and Pharmaceutical University(JP)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Glycosylation and Glycoproteins Research, RNA modifications and cancer, Cancer-related molecular mechanisms research
Most-Cited Works
- → Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer(2019)156 cited
- → Using Proteomic Approach to Identify Tumor-Associated Proteins as Biomarkers in Human Esophageal Squamous Cell Carcinoma(2011)150 cited
- → Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer(2017)141 cited
- → Abstract 2808: Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450(2015)97 cited
- → Autoantibodies against tumor-associated antigens in the early detection of lung cancer(2016)71 cited
- → Polymorphisms in lncRNA HOTAIR and susceptibility to breast cancer in a Chinese population